Director/PDMR Shareholding
Updated : 20:37
SMITH & NEPHEW PLC
28 October 2022
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2022 interim dividend payment on 26 October 2022. |
Date of Transaction | 2022 - 10 - 26 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) | Director / PDMR | Price | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
Bradley Cannon (President, Orthopaedics, Sports Medicine & ENT, Americas) | PDMR | £10.01893 | 0.00671 | N/A Single Transaction | 100,240.72690 (including 3,115.77575 in ADS') | 0.01142% |
Peter Coenen (President, EMEA) | PDMR | £10.01893 | 15.6384 | N/A Single Transaction | 1,229.27131 | 0.00014% |
Phil Cowdy (Chief Business Development & Corporate Affairs Officer) | PDMR | £10.01893 | 0.01263 | N/A Single Transaction | 47,133.99309 | 0.00537% |
Myra Eskes (President APAC and Global Service) | PDMR | £10.01893 | 350.27072 | N/A Single Transaction | 27,533.36775 | 0.00314% |
Simon Fraser (President AWM and Global Commercial Operations) | PDMR | £10.01893 | 353.05042 | N/A Single Transaction | 27,751.86880 | 0.00316% |
Alison Parkes (Chief Compliance Officer) | PDMR | £10.01893 | 27.8458 | N/A Single Transaction | 3,993.17067 (including 712.66244 in ADS') | 0.00045% |
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.